# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001641172-25-017288
Filing Date
2025-07-01
Accepted
2025-07-01 09:00:33
Documents
16
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 38778
2 | EX-10.1 | ex10-1.htm | EX-10.1 | 1589
3 | EX-99.1 | ex99-1.htm | EX-99.1 | 23843
4 | GRAPHIC | ex10-1_001.jpg | GRAPHIC | 729170
5 | GRAPHIC | ex10-1_002.jpg | GRAPHIC | 1004145
| Complete submission text file | 0001641172-25-017288.txt |  | 2619786

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | pcsa-20250627.xsd | EX-101.SCH | 3059
7 | XBRL LABEL FILE | pcsa-20250627_lab.xml | EX-101.LAB | 34239
8 | XBRL PRESENTATION FILE | pcsa-20250627_pre.xml | EX-101.PRE | 22388
18 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3687

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 251094293
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)